IONS (STOCKS)
Ionis Pharmaceuticals, Inc. Common Stock
$84.350000
+0.060000 (+0.07%)
Prev close: $84.290000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brett P. Monia
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,654.41M
- Employees
- 927
- P/E (TTM)
- -49.25
- P/B (TTM)
- 21.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
13
Buy
7
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.80 | $-1.26 | +0.4582 | +36.42% |
|
Jun 2025 (Q2)
|
$0.70 | $-0.44 | +1.1387 | +259.56% |
|
Mar 2025 (Q1)
|
$-0.93 | $-1.14 | +0.2091 | +18.36% |
|
Dec 2024 (Q4)
|
$-0.66 | $-1.15 | +0.4856 | +42.39% |
Financial Statements
| Revenues | $966.96M |
| Benefits Costs and Expenses | $1.23B |
| Cost Of Revenue | $11.78M |
| Costs And Expenses | $1.25B |
| Gross Profit | $955.18M |
| Operating Expenses | $1.24B |
| Selling, General, and Administrative Expenses | $351.76M |
| Other Operating Expenses | $881.46M |
| Operating Income/Loss | -$278.05M |
| Income/Loss From Continuing Operations After Tax | -$256.34M |
| Income/Loss From Continuing Operations Before Tax | -$262.51M |
| Income Tax Expense/Benefit | -$2.38M |
| Interest Expense, Operating | $16.63M |
| Net Income/Loss | -$256.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$256.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$256.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.61 |
| Diluted Earnings Per Share | -$1.61 |
| Basic Average Shares | 162,027,000 |
| Diluted Average Shares | 162,027,000 |
| Assets | $3.03B |
| Current Assets | $2.52B |
| Inventory | $10.47M |
| Other Current Assets | $2.51B |
| Noncurrent Assets | $514.10M |
| Fixed Assets | $106.12M |
| Other Non-current Assets | $407.98M |
| Liabilities | $2.42B |
| Current Liabilities | $903.46M |
| Accounts Payable | $14.33M |
| Wages | $57.02M |
| Other Current Liabilities | $832.11M |
| Noncurrent Liabilities | $1.51B |
| Equity | $617.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $617.97M |
| Liabilities And Equity | $3.03B |
| Net Cash Flow From Operating Activities | -$247.01M |
| Net Cash Flow From Operating Activities, Continuing | -$247.01M |
| Net Cash Flow From Investing Activities | $209.94M |
| Net Cash Flow From Investing Activities, Continuing | $209.94M |
| Net Cash Flow From Financing Activities | $40.55M |
| Net Cash Flow From Financing Activities, Continuing | $40.55M |
| Net Cash Flow | $3.48M |
| Net Cash Flow, Continuing | $3.48M |
| Comprehensive Income/Loss | -$251.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$251.51M |
| Other Comprehensive Income/Loss | -$147.16M |